title: Regression of hypertrophy after Carpentier-Edwards pericardial aortic valve replacement.
abstract: BACKGROUND
  The purpose of this study was to determine whether significant regression of left ventricular hypertrophy is seen after implantation of small sizes (19 to 23 mm) of the Carpentier-Edwards (CE) pericardial valve, a stented pericardial valve.
  
  
  METHODS
  Echocardiograms and electrocardiograms (ECGs) were performed at least 1 year after surgery (mean 18 months) in patients with 19-, 21-, and 23-mm CE pericardial aortic valves and compared with preoperative echocardiograms and ECGs.
  
  
  RESULTS
  A total of 41 patients, mean age 79 +/- 9 years (range 46 to 93 years), were studied, including 7 19-mm, 22 21-mm, and 12 23-mm patients. The mean postoperative gradient was 22 +/- 7 mm Hg for 19-mm valves, 18 +/- 5 mm Hg for 21-mm valves, and 16 +/- 4 mm Hg for 23-mm valves. The postoperative valve areas were 1.1 +/- 0.3 cm2 for the 19-mm, 1.3 +/- 0.3 cm2 for the 21-mm, and 1.5 +/- 0.4 cm2 for the 23-mm valves. Left ventricular end diastolic diameter, end systolic diameter, septal thickness, and posterior wall thickness all decreased significantly (p <0.05) postoperatively. The proportion of patients with significant left ventricular hypertrophy on ECG decreased from 63% to 47% (p = 0.001). Left ventricular mass decreased significantly by echocardiography from 265 g preoperatively to 208 g postoperatively (p = 0.004). Left ventricular mass decreased for each valve size, and the greatest absolute reduction in mass occurred in the 19-mm valve recipients.
  
  
  CONCLUSIONS
  Implantation of the 19-, 21-, and 23-mm CE pericardial valves results in significant reductions in left ventricular mass. These findings suggest that stented pericardial valves can be used in the small aortic root without the need for aortic root enlargement procedures.
authors.affiliation: Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA. khan@csmc.edu
authors.forename: S S
authors.initials: SS
authors.lastname: Khan
authors.forename: R J
authors.initials: RJ
authors.lastname: Siegel
authors.forename: M A
authors.initials: MA
authors.lastname: DeRobertis
authors.forename: C E
authors.initials: CE
authors.lastname: Blanche
authors.forename: R M
authors.initials: RM
authors.lastname: Kass
authors.forename: W
authors.initials: W
authors.lastname: Cheng
authors.forename: G P
authors.initials: GP
authors.lastname: Fontana
authors.forename: A
authors.initials: A
authors.lastname: Trento
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001021:Aortic Valve; D005260:Female; D006349:Heart Valve Diseases / Q000150:complications / Q000503:physiopathology; D019918:Heart Valve Prosthesis Implantation; D006439:Hemodynamics; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D016277:Ventricular Function, Left